1 / 10

LCC REC-1

Rectal Cancer. π. Φ. See Primary and Adjuvant Treatment (LCC REC-3). Observe or See Primary Treatment (LCC REC-3). π. See Primary and Adjuvant Treatment (LCC REC-3). Φ. Φ. π. LCC REC-1. Rectal Cancer. See Primary Treatment (LCC REC-3). See Primary Treatment (LCC REC-4).

hiram-spence
Download Presentation

LCC REC-1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rectal Cancer π Φ See Primary and Adjuvant Treatment (LCC REC-3) Observe or See Primary Treatment (LCC REC-3) π See Primary and Adjuvant Treatment (LCC REC-3) Φ Φ π LCCREC-1

  2. Rectal Cancer See Primary Treatment (LCC REC-3) See Primary Treatment (LCC REC-4) See Primary Treatment (LCC REC-4) See Primary Treatment (LCC REC-5) See Primary Treatment (LCC REC-6) LCCREC-2

  3. Rectal Cancer Chemoradiotherapy Surveillance (See LCC REC-7) Φ Chemoradiotherapy Φ High risk features include positive margins, lymphovascular invasion and poorly differentiated tumors. LCCREC-3

  4. Rectal Cancer π Preoperative chemoradiation (Neoadjuvant Chemoradiotherapy) Chemotherapy Surveillance (See LCC REC-7) Φ Reconsider adjuvant Chemoradiotherapy Chemoradiotherapy Chemotherapy Φ π LCCREC-4

  5. Rectal Cancer Chemoradiotherapy Chemotherapy Φ Chemoradiotherapy Surveillance (See LCC REC-7) Chemotherapy Chemoradiotherapy Chemoradiotherapy Φ LCCREC-5

  6. Rectal Cancer Chemoradiotherapy or Resection of involved rectal segment or Diverting colostomy or Chemotherapy alone Chemotherapy LCCREC-6

  7. Rectal Cancer Φ π See Workup and Treatment (LCC REC-8) † Φ If patient is a potential candidate for resection of isolated metastasis. High risk for recurrence (eg, lymphatic or venous invasion by tumor, or poorly differentiated tumors). Villous polyp, polyp > 1 cm, or high grade dysplasia. π † LCCREC-7

  8. Rectal Cancer Reevaluate chest/abdominal/pelvic CT in 3-6 months See treatment for Documented metachronous metastases (LCC REC-9) See treatment for Documented metachronous metastases (LCC REC-9) See treatment for Documented metachronous metastases (LCC COL-8) Preoperative chemoradiotherapy Φ Resection, if feasible See treatment for Documented metachronous metastases (LCC REC-9) Φ Radiation, if not given previously. LCCREC-8

  9. Rectal Cancer See Primary Treatment (LCC REC-10) π Chemotherapy π π Therapy may be considered for a maximum of 6 months. LCCREC-9

  10. Rectal Cancer Chemotherapy π π π Chemotherapy π π Therapy may be considered for a maximum of 6 months. LCCREC-10

More Related